Skip to main content

Table 1 General characteristics and factors associated with ESA prescription: univariate analysis (Student T-test test or chi square test as appropriate, n = 240 patients)

From: Indole 3-acetic acid, indoxyl sulfate and paracresyl-sulfate do not influence anemia parameters in hemodialysis patients

 

Total population (n = 240)

Patients without ESA (n = 71)

Patients with ESA (n = 169)

p-value

Age (years)

67.6 ± 16.0

68.6 ± 14.8

67.3 ± 16.6

0.56

Male gender

55.4%

62.0%

52.7%

0.19

Time on dialysis (months)

82 ± 121

80 ± 89

83 ± 133

0.87

Diabetes mellitus

42.5%

43.7%

42.0%

0.81

Dry weight (kg)

69.6 ± 14.9

71.4 ± 15.6

68.9 ± 14.6

0.23

ADPKD

4.6%

4.2%

4.7%

1.00

White cell count (G/L)

7.01 ± 4.62

6.55 ± 2.05

7.21 ± 5.34

0.31

Lymphocytes (G/L)

1.28 ± 0.58

1.34 ± 0.62

1.25 ± 0.57

0.27

Hemoglobin (g/dL)

10.8 ± 1.2

11.4 ± 1.1

10.6 ± 1.2

<0.001

MCV (fl)

94 ± 8

93 ± 6

95 ± 8

0.33

Platelet count (G/L)

203 ± 79

187 ± 70

209 ± 82

0.06

TSAT (%)

25.5 ± 13.5

31.1 ± 16.3

23.1 ± 11.5

<0.001

Ferritin (ng/mL)

530 ± 520

577 ± 640

510 ± 461

0.36

Albumin (g/L)

37.7 ± 5.3

37.9 ± 4.8

37.6 ± 5.5

0.65

β2 microglobulin (mg/L)

26.6 ± 7.4

27.4 ± 7.9

26.4 ± 7.1

0.40

Parathormone (pg/mL)

256 ± 318

263 ± 313

252 ± 119

0.82

Predialysis creatinine (μmol/L)

732 ± 253

748 ± 273

725 ± 244

0.52

Predialysis urea (mmol/L)

20.7 ± 6.6

20.4 ± 5.9

20.8 ± 6.8

0.64

C-reactive protein (mg/L)

20.0 ± 43.5

16.6 ± 37.8

21.4 ± 45.7

0.44

IAA (μmol/L)

4.73 ± 4.79

4.79 ± 5.06

4.71 ± 4.69

0.91

IS (μmol/L)

93.3 ± 51.5

91.1 ± 53.0

94.2 ± 51.0

0.67

PCS(μmol/L)

158 ± 99

165 ± 99

154 ± 99

0.44

ESA dose (μg/w)

-

-

53.9 ± 50.0

-

IV iron medication (%)

61.7%

52.1%

65.7%

0.04

Iron dose (mg/mo)

232 ± 267

173 ± 200

257 ± 288

0.03

Vascular access

 Native AV fistula

63.3%

54.9%

66.9%

0.17

 AV graft

16.7%

18.3%

16.0%

 

 Catheter

20.0%

26.8%

17.2%

 

HDF (%)

41.7%

53.5%

36.7%

0.02

Kt/V

1.51 ± 0.31

1.51 ± 0.26

1.51 ± 0.32

0.98

  1. Results are provided as mean ± SD or percentages. ESA erythropoiesis stimulating agent, ADPKD autosomal dominant polycystic disease, MCV mean corpuscular volume, IS indoxylsulfate, IAA indole-3-acetic acid, PCS paracresyl-sulfate, AV arteriovenous, HDF hemodiafiltration